Spleen-targeted neoantigen mRNA vaccine induces ISG15+ CD8+ T cell-mediated tertiary lymphoid structure formation in hepatocellular carcinoma
Abstract
T cells and antigen-presenting cells (APCs), which is also confirmed in HCC patients. Taken together, our findings demonstrate the potent antitumor efficacy of spleen-targeted mRNA vaccine and reveal its underlying immune cell interactive mechanisms, presenting high potential for clinical translation.
Fields of Study & Subjects
interferon and immune responses
Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
Publication details
- Journal / source
- Cell Reports Medicine
- Publisher
- Elsevier BV
- Volume
- 7
- Issue
- 5
- Pages
- 102754–102754
- Publication date
- 20 April 2026
- Language
- EN